NYSE:HIMSHealthcare
Hims And Hers Wegovy Talks Could Reshape Growth And Subscriber Economics
Hims & Hers Health (NYSE:HIMS) is in discussions with Novo Nordisk to add Wegovy injections to its telehealth platform.
The talks also include potential access to an oral version of Wegovy for weight management.
The move would introduce a new category of prescription weight loss treatments to the company’s existing offerings.
Hims & Hers Health runs a direct-to-consumer telehealth and subscriptions model focused on areas like hair loss, mental health, skincare, and sexual health. Bringing a...